$LPCN
Lipocine Inc. Stock $lpcn

$lpcn Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000149315222031032 Filed on November 09, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q4
Revenue	$0.00		$16.09M
YoY Change	-100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$890.3K	$798.9K	$1.048M
YoY Change	-15.05%	-34.63%	-54.82%
% of Gross Profit
Research & Development	$1.670M	$2.100M	$2.254M
YoY Change	-25.88%	-11.24%	-9.12%
% of Gross Profit
Depreciation & Amortization	$2.570K	$2.580K	$380.00
YoY Change	576.32%
% of Gross Profit
Operating Expenses	$2.561M	$2.899M	$3.302M
YoY Change	-22.44%	-19.21%	-31.21%
Operating Profit		-$2.899M
YoY Change		-17.95%
Interest Expense	$297.2K		-$9.610K
YoY Change	-3192.2%		-87.99%
% of Operating Profit
Other Income/Expense, Net	$34.24K	$490.2K	-$150.3K
YoY Change	-122.78%	2.14%	-215.63%
Pretax Income	-$2.229M	-$2.409M	$12.62M
YoY Change	-117.66%	-21.81%	-379.91%
Income Tax	$480.00		$0.00
% Of Pretax Income			0.0%
Net Earnings	-$2.230M	-$2.409M	$12.62M
YoY Change	-117.66%	-21.81%	-379.91%
Net Earnings / Revenue			78.48%
Basic Earnings Per Share		-$0.03
Diluted Earnings Per Share	-$0.02	-$0.03	$143.0K
COMMON SHARES
Basic Shares Outstanding	88.51M shares	88.51M shares
Diluted Shares Outstanding		88.77M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$32.53M	$34.26M	$44.62M
YoY Change	-27.09%	-11.4%	126.83%
Cash & Equivalents	$3.148M	$2.397M	$2.951M
Short-Term Investments	$29.38M	$31.86M	$41.67M
Other Short-Term Assets	$1.525M	$1.814M	$1.514M
YoY Change	0.68%	17.51%	-73.24%
Inventory
Prepaid Expenses
Receivables	$80.43K	$40.77K	$247.3K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$34.14M	$36.11M	$46.38M
YoY Change	-26.4%	-10.54%	83.1%
LONG-TERM ASSETS
Property, Plant & Equipment	$131.6K	$37.44K	$7.210K
YoY Change	1725.09%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$0.00	$2.022M
YoY Change	-100.0%
Other Assets	$23.75K	$23.75K	$23.75K
YoY Change	0.01%	0.01%	18.75%
Total Long-Term Assets	$3.408M	$3.314M	$6.103M
YoY Change	-44.16%	13852.37%	30413.8%
TOTAL ASSETS
Total Short-Term Assets	$34.14M	$36.11M	$46.38M
Total Long-Term Assets	$3.408M	$3.314M	$6.103M
Total Assets	$37.54M	$39.42M	$52.48M
YoY Change	-28.47%	-2.39%	107.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$600.4K	$630.5K	$1.289M
YoY Change	-53.43%	-13.11%	-19.42%
Accrued Expenses	$1.078M	$880.9K	$2.016M
YoY Change	-46.55%	-65.74%	22.21%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$2.311M
YoY Change	-100.0%	-100.0%	-30.61%
Total Short-Term Liabilities	$1.678M	$1.511M	$5.617M
YoY Change	-70.12%	-76.51%	-14.64%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$229.9K	$264.1K	$1.296M
YoY Change	-82.26%	-76.94%	10.75%
Total Long-Term Liabilities	$229.9K	$264.1K	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.678M	$1.511M	$5.617M
Total Long-Term Liabilities	$229.9K	$264.1K	$0.00
Total Liabilities	$1.908M	$1.775M	$6.912M
YoY Change	-72.4%	-76.57%	-30.94%
SHAREHOLDERS EQUITY
Retained Earnings	-$183.4M	-$181.2M	-$172.7M
YoY Change	6.23%
Common Stock	$8.852K	$8.851K	$8.829K
YoY Change	0.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$40.71K	$40.71K	$40.71K
YoY Change	0.0%
Treasury Stock Shares	5.710K shares	5.710K shares	5.710K shares
Shareholders Equity	$35.63M	$37.65M	$45.57M
YoY Change
Total Liabilities & Shareholders Equity	$37.54M	$39.42M	$52.48M
YoY Change	-28.47%	-2.39%	107.03%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q4
OPERATING ACTIVITIES
Net Income	-$2.230M	-$2.409M	$12.62M
YoY Change	-117.66%	-21.81%	-379.91%
Depreciation, Depletion And Amortization	$2.570K	$2.580K	$380.00
YoY Change	576.32%
Cash From Operating Activities	-$1.839M	-$3.198M	$8.995M
YoY Change	-120.44%	-54.19%	-344.42%
INVESTING ACTIVITIES
Capital Expenditures	$96.73K	$0.00	-$7.590K
YoY Change	-1374.44%
Acquisitions
YoY Change
Other Investing Activities	$2.693M	$613.9K	-$9.715M
YoY Change	-127.72%	-55.14%	-279.58%
Cash From Investing Activities	$2.596M	$613.9K	-$9.723M
YoY Change	-126.7%	-55.14%	-279.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-5.900K	50.00	-838.5K
YoY Change	-99.3%	-100.01%	-118.39%
NET CHANGE
Cash From Operating Activities	-1.839M	-3.198M	8.995M
Cash From Investing Activities	2.596M	613.9K	-9.723M
Cash From Financing Activities	-5.900K	50.00	-838.5K
Net Change In Cash	751.5K	-2.584M	-1.567M
YoY Change	-147.97%	-59.94%	-124.91%
FREE CASH FLOW
Cash From Operating Activities	-$1.839M	-$3.198M	$8.995M
Capital Expenditures	$96.73K	$0.00	-$7.590K
Free Cash Flow	-$1.936M	-$3.198M	$9.002M
YoY Change	-121.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2021Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization		usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset		usd
	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty		usd
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	lpcn	Dilutive Common Stock Warrants Attributable To Common Stock Shares DilutiveCommonStockWarrantsAttributableToCommonStockShares	719362	shares
	lpcn	End Of Loan Payment EndOfLoanPayment		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	lpcn	Settlement Of Warrant Liability On Warrant Exercises SettlementOfWarrantLiabilityOnWarrantExercises		usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2022Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax		usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	lpcn	Adjustment Of Warrants For Settlement Of Liability On Warrant Exercise AdjustmentOfWarrantsForSettlementOfLiabilityOnWarrantExercise		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent		usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent		usd
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-36357
	dei	Entity Registrant Name EntityRegistrantName	LIPOCINE INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	99-0370688
	dei	Entity Address Address Line1 EntityAddressAddressLine1	675 Arapeen Drive
CY2022Q3	us-gaap	Debt Current DebtCurrent		usd
CY2022Q3	us-gaap	Litigation Reserve Current LitigationReserveCurrent		usd
CY2022Q3	us-gaap	Litigation Reserve Noncurrent LitigationReserveNoncurrent		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Interest Expense InterestExpense		usd
CY2022Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001535955
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 202
	dei	Entity Address City Or Town EntityAddressCityOrTown	Salt Lake City
	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84108
	dei	City Area Code CityAreaCode	801
	dei	Local Phone Number LocalPhoneNumber	994-7383
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
	dei	Trading Symbol TradingSymbol	LPCN
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	88510791	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2396960	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2950552	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	31858842	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	41667405	usd
CY2022Q3	us-gaap	Interest Receivable Current InterestReceivableCurrent	40774	usd
CY2021Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	247253	usd
CY2022Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	579428	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1234536	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1514465	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	36110540	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	46379675	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	2021800	usd
CY2022Q3	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	3252500	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	4050000	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1150952	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1144077	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	37435	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7211	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	23753	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	23753	usd
CY2022Q3	us-gaap	Assets Assets	39424228	usd
CY2021Q4	us-gaap	Assets Assets	52482439	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	630456	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1289342	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	880850	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1016458	usd
CY2021Q4	us-gaap	Debt Current DebtCurrent	2310825	usd
CY2021Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	1000000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1511306	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5616625	usd
CY2022Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	264099	usd
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	795796	usd
CY2021Q4	us-gaap	Litigation Reserve Noncurrent LitigationReserveNoncurrent	500000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	1775405	usd
CY2021Q4	us-gaap	Liabilities Liabilities	6912421	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	88516501	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	88296360	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	88510791	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	88290650	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	8851	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	8829	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	218952749	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	218286324	usd
CY2022Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	5710	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	5710	shares
CY2022Q3	us-gaap	Treasury Stock Value TreasuryStockValue	40712	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	40712	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-76935	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-18016	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-181195130	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-172666407	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	37648823	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	45570018	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	39424228	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52482439	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	54994	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	500000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	54994	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2100432	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2366521	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6886398	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5411748	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	798939	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1222146	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3172144	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4281690	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	2899371	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	3588667	usd
	us-gaap	Operating Expenses OperatingExpenses	10058542	usd
	us-gaap	Operating Expenses OperatingExpenses	9693438	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2899371	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3533673	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9558542	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9638444	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	163966	usd
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	17264	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	275420	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	45257	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	44839	usd
	us-gaap	Interest Expense InterestExpense	27098	usd
	us-gaap	Interest Expense InterestExpense	171241	usd
CY2022Q3	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	326240	usd
CY2021Q3	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	479951	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	531697	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	506208	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	250000	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-4000000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	490206	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	452376	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1030019	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3619776	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2409165	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3081297	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8528523	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13258220	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2409165	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3081297	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8528723	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13258420	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	88506479	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	88290650	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	88439198	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86477640	shares
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	88771698	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	88963899	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	88945040	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	87197002	shares
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2409165	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3081297	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8528723	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13258420	usd
CY2022Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	7972	usd
CY2021Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-3234	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-58919	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-3420	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2401193	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3084531	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8587642	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13261840	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	35745553	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3081297	usd
CY2021Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-3234	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	154998	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	4932	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	32811088	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	15341919	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13258420	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-3420	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	449311	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6693	usd
	lpcn	Common Stock Sold Through Equity Offering CommonStockSoldThroughEquityOffering	26840457	usd
	lpcn	Stock Issued During Period Value Warrants Exercises StockIssuedDuringPeriodValueWarrantsExercises	5000	usd
	lpcn	Adjustments To Additional Paid In Capital Settlement Of Warrant Liability On Warrant Exercises AdjustmentsToAdditionalPaidInCapitalSettlementOfWarrantLiabilityOnWarrantExercises	18365	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3411183	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	32811088	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	39889745	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2409165	usd
CY2022Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	7972	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	160227	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5344	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	5300	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	37648823	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	45570018	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8528723	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-58919	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-58919	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	470824	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	211423	usd
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	15800	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	37648823	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8528723	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13258420	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6875	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	470824	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	449311	usd
	us-gaap	Accretion Expense AccretionExpense	5842	usd
	us-gaap	Accretion Expense AccretionExpense	45571	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-531697	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-506208	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-36988	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-358959	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-206479	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	158839	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-218072	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-279929	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	882383	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-658886	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-871668	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-135608	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-82166	usd
	lpcn	Litigation Settlement Liability LitigationSettlementLiability	-1250000	usd
	lpcn	Litigation Settlement Liability LitigationSettlementLiability	1500000	usd
	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	250000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10129905	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13405843	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	37099	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	33567544	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	37307767	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	45302000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	3250000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	11697357	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-34057767	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	1666667	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	2500000	usd
	lpcn	End Of Loan Payment EndOfLoanPayment	650000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	26840457	usd
	lpcn	Proceeds From Repayments Of Costs Associated With Offering ProceedsFromRepaymentsOfCostsAssociatedWithOffering	-15800	usd
	lpcn	Proceeds From Repayments Of Costs Associated With Offering ProceedsFromRepaymentsOfCostsAssociatedWithOffering	3411183	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	211423	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6693	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	5000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2121044	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	27763333	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-553592	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-19700277	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2950552	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	24217382	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2396960	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4517105	usd
	us-gaap	Interest Paid Net InterestPaidNet	21256	usd
	us-gaap	Interest Paid Net InterestPaidNet	125670	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	200	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	200	usd
	lpcn	Settlement Of Warrant Liability On Warrant Exercises SettlementOfWarrantLiabilityOnWarrantExercises	18365	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-58919	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-3420	usd
	lpcn	Accrued Final Payment Charge On Debt AccruedFinalPaymentChargeOnDebt	5842	usd
	lpcn	Accrued Final Payment Charge On Debt AccruedFinalPaymentChargeOnDebt	45571	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	500000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	55000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	55000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2409165	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3081297	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8528723	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13258420	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	88506479	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	88290650	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	88439198	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86477640	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2409165	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3081297	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8528723	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13258420	usd
CY2022Q3	lpcn	Dilutive Common Stock Warrants Attributable To Common Stock DilutiveCommonStockWarrantsAttributableToCommonStock	326240	usd
CY2021Q3	lpcn	Dilutive Common Stock Warrants Attributable To Common Stock DilutiveCommonStockWarrantsAttributableToCommonStock	479951	usd
	lpcn	Dilutive Common Stock Warrants Attributable To Common Stock DilutiveCommonStockWarrantsAttributableToCommonStock	531697	usd
	lpcn	Dilutive Common Stock Warrants Attributable To Common Stock DilutiveCommonStockWarrantsAttributableToCommonStock	506208	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2735405	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3561248	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-9060420	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-13764628	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	88506479	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	88290650	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	88439198	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86477640	shares
CY2022Q3	lpcn	Dilutive Common Stock Warrants Attributable To Common Stock Shares DilutiveCommonStockWarrantsAttributableToCommonStockShares	265219	shares
CY2021Q3	lpcn	Dilutive Common Stock Warrants Attributable To Common Stock Shares DilutiveCommonStockWarrantsAttributableToCommonStockShares	673249	shares
	lpcn	Dilutive Common Stock Warrants Attributable To Common Stock Shares DilutiveCommonStockWarrantsAttributableToCommonStockShares	505842	shares
CY2022Q3	lpcn	Weighted Average Effect Of Diluted Shares Outstanding WeightedAverageEffectOfDilutedSharesOutstanding	88771698	shares
CY2021Q3	lpcn	Weighted Average Effect Of Diluted Shares Outstanding WeightedAverageEffectOfDilutedSharesOutstanding	88963899	shares
	lpcn	Weighted Average Effect Of Diluted Shares Outstanding WeightedAverageEffectOfDilutedSharesOutstanding	88945040	shares
	lpcn	Weighted Average Effect Of Diluted Shares Outstanding WeightedAverageEffectOfDilutedSharesOutstanding	87197002	shares
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2022Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	31935777	usd
CY2022Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	76935	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	31858842	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	43707221	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	18016	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	43689205	usd
CY2022Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1400000	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	31935777	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	31858842	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	31935777	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	31858842	usd
CY2022Q3	us-gaap	Proceeds From Sale Of Held To Maturity Securities ProceedsFromSaleOfHeldToMaturitySecurities	0	usd
	us-gaap	Proceeds From Sale Of Held To Maturity Securities ProceedsFromSaleOfHeldToMaturitySecurities	0	usd
CY2021Q3	us-gaap	Proceeds From Sale Of Held To Maturity Securities ProceedsFromSaleOfHeldToMaturitySecurities	0	usd
	us-gaap	Proceeds From Sale Of Held To Maturity Securities ProceedsFromSaleOfHeldToMaturitySecurities	0	usd
CY2022Q3	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	0	usd
	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	0	usd
CY2021Q3	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	0	usd
	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	0	usd
CY2022Q3	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	11500000	usd
CY2021Q3	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	2800000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	45300000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	3300000	usd
CY2022Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	33721817	usd
CY2022Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	33985916	usd
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	45778956	usd
CY2021Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	46574752	usd
CY2021Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1800000	usd
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	4600000	usd
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	3400000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	449311	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	85910	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	57273	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	143183	usd
CY2022Q3	us-gaap	Payments For Rent PaymentsForRent	86000	usd
CY2021Q3	us-gaap	Payments For Rent PaymentsForRent	83000	usd
	us-gaap	Payments For Rent PaymentsForRent	256000	usd
	us-gaap	Payments For Rent PaymentsForRent	248000	usd
CY2019Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.50
CY2015Q4	lpcn	Class Of Warrants Or Right Redemption Price Of Warrants Or Rights ClassOfWarrantsOrRightRedemptionPriceOfWarrantsOrRights	63.96
	lpcn	Class Of Warrants Or Right Redemption Price Of Warrants Or Rights ClassOfWarrantsOrRightRedemptionPriceOfWarrantsOrRights	0.001
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	160000	usd
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	155000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	471000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	449000	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	160227	usd
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	154998	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	470824	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y9M10D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y8M12D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0198	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0052	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.0150	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.9552	pure
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	956000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y9M18D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3992937	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M17D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.63
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2663444	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y8M12D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.38
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	795796	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-531697	usd
CY2022Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	264099	usd
CY2019Q4	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	1250000	usd

Files In Submission

Name	View Source	Status
0001493152-22-031032-index-headers.html	Edgar Link	pending
0001493152-22-031032-index.html	Edgar Link	pending
0001493152-22-031032.txt	Edgar Link	pending
0001493152-22-031032-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
form10-q_002.jpg	Edgar Link	pending
form10-q_004.jpg	Edgar Link	pending
lpcn-20220930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
lpcn-20220930_cal.xml	Edgar Link	unprocessable
lpcn-20220930_def.xml	Edgar Link	unprocessable
lpcn-20220930_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
lpcn-20220930_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LPCN
Lipocine Inc. Stock $lpcn

2022 Q4 Form 10-Q Financial Statement

#000149315222031032 Filed on November 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LPCN Lipocine Inc. Stock $lpcn

2022 Q4 Form 10-Q Financial Statement

#000149315222031032 Filed on November 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LPCN
Lipocine Inc. Stock $lpcn